Australia markets closed

Corcept Therapeutics Incorporated (CORT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
21.25+0.35 (+1.67%)
At close: 04:00PM EDT
21.25 -0.00 (-0.01%)
After hours: 04:05PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
101,418
101,418
112,512
106,011
94,181
Depreciation & amortisation
2,969
2,969
3,067
2,237
2,171
Deferred income taxes
-33,905
-33,905
4,346
14,089
16,877
Stock-based compensation
42,442
42,442
42,931
33,539
29,313
Change in working capital
6,016
6,016
-57
-5,357
-4,687
Accounts receivable
-3,432
-3,432
-1,427
-6,270
-2,340
Inventory
1,199
1,199
3,444
-3,514
-1,044
Accounts payable
4,757
4,757
-3,597
3,161
-735
Other working capital
119,910
119,910
167,423
150,732
135,029
Other non-cash items
1,383
1,383
5,093
1,451
-1,738
Net cash provided by operating activities
120,323
120,323
167,892
151,970
136,117
Cash flows from investing activities
Investments in property, plant and equipment
-413
-413
-469
-1,238
-1,088
Purchases of investments
-355,066
-355,066
-312,805
-420,114
-299,035
Sales/maturities of investments
241,152
241,152
449,400
302,089
182,295
Net cash used for investing activities
-114,327
-114,327
136,126
-119,263
-117,828
Cash flows from financing activities
Debt repayment
-
-
-
-
0
Common stock repurchased
0
0
-295,985
-9,945
-30,975
Other financing activities
-21,665
-21,665
-22,835
-1,067
-6,089
Net cash used provided by (used for) financing activities
-17,284
-17,284
-302,591
12,214
-28,645
Net change in cash
-11,288
-11,288
1,427
44,921
-10,356
Cash at beginning of period
77,617
77,617
76,190
31,269
41,625
Cash at end of period
66,329
66,329
77,617
76,190
31,269
Free cash flow
Operating cash flow
120,323
120,323
167,892
151,970
136,117
Capital expenditure
-413
-413
-469
-1,238
-1,088
Free cash flow
119,910
119,910
167,423
150,732
135,029